Inventor · disambiguated record
Ed Yaworski
Also filed as: YAWORSKI ED
12 granted patents·10 pending applications·907 citations·filing 1996–2024
94Inventor score
Top patents by PatentIndex Score
22 records- 0198US12016929B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Jun 25, 2024·5 cites·22 claims
- 0298US11786598B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Oct 17, 2023·7 cites·17 claims
- 0398US11718852B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 8, 2023·5 cites·32 claims
- 0498US9878042B2Lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·23 cites·18 claims
- 0598US9518272B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·116 cites·22 claims
- 0698US9404127B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·131 cites·22 claims
- 0798US8283333B2Lipid formulations for nucleic acid deliveryYAWORSKI ED·Filed 2010·Granted Oct 9, 2012·313 cites·39 claims
- 0897US12129467B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 29, 2024·2 cites·24 claims
- 0997US9006417B2Non-liposomal systems for nucleic acid deliveryYAWORSKI ED·Filed 2011·Granted Apr 14, 2015·55 cites·24 claims
- 1096US8236943B2Compositions and methods for silencing apolipoprotein BLEE AMY C H·Filed 2010·Granted Aug 7, 2012·234 cites·26 claims
- 1195US11446383B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Sep 20, 2022·6 cites·17 claims
- 1292US2024316206A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 1391US2025034571A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 1489US2024035030A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 1588US2024100166A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 1672US2018071397A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1772US2019032051A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 1867US2013122104A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsYAWORSKI ED·Filed 2012·Application pending·0 cites
- 1967US2017260523A1Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2056US2023001021A1Ornithine transcarbamylase (otc) constructs and methods of using the samePRIEVE MARY·Filed 2020·Application pending·0 cites
- 2141US2013022649A1Snalp formulations containing antioxidantsPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2238US5691173AFermentation process for preparation of compactinAPOTEX INC·Filed 1996·Granted Nov 25, 1997·10 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Ed Yaworski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →